Scarica l'app Stockscreener
23.35
1.24%
0.28
Precedente Chiudi:
$23.07
Aprire:
$23.07
Volume 24 ore:
52,180
Relative Volume:
0.20
Capitalizzazione di mercato:
$1.04B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+12.28%
1M Prestazione:
+63.55%
6M Prestazione:
+308.30%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$22.64
$24.00
Intervallo di 1 settimana:
$20.18
$24.00
Portata 52W:
$4.17
$28.99
Septerna Inc Stock (SEPN) Company Profile
Nome
Septerna Inc
Settore
Industria
Telefono
650-338-3533
Indirizzo
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Confronta SEPN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
23.34 | 1.03B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.28 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.63 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.19 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.57 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.93 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-23 | Iniziato | H.C. Wainwright | Buy |
| 2025-02-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-11-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-11-19 | Iniziato | JP Morgan | Overweight |
| 2024-11-19 | Iniziato | TD Cowen | Buy |
| 2024-11-19 | Iniziato | Wells Fargo | Overweight |
Mostra tutto
Septerna Inc Borsa (SEPN) Ultime notizie
Is Septerna Inc. stock a safe haven assetJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com
Momentum divergence signals in Septerna Inc. chartJuly 2025 Summary & Community Verified Swing Trade Signals - newser.com
Septerna (NASDAQ:SEPN) Shares Gap DownHere's Why - MarketBeat
Will Septerna’s (SEPN) Latest Board Appointment Strengthen Its R&D Edge or Reinforce the Status Quo? - simplywall.st
Using data tools to time your Septerna Inc. exitMarket Performance Report & Real-Time Buy Zone Alerts - newser.com
Septerna Inc Stock Analysis and ForecastEarnings Beat Highlights & Maximize Gains Professionally - earlytimes.in
What drives Septerna Inc stock priceTechnical Breakout Signals & Outperform With Our Smart Trading Calculator - earlytimes.in
Septerna (SEPN): Evaluating Valuation Following Dr. Keith Gottesdiener’s Board Appointment - Yahoo Finance
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength? - Yahoo Finance
Visual analytics tools that track Septerna Inc. performancePortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Septerna (NASDAQ:SEPN) - MarketBeat
Multi asset correlation models including Septerna Inc.Trade Risk Assessment & Free High Return Stock Watch Alerts - newser.com
Price momentum metrics for Septerna Inc. explainedGold Moves & Short-Term Trading Alerts - newser.com
How Septerna Inc. stock performs in high volatility markets2025 Winners & Losers & Daily Profit Focused Screening - newser.com
Septerna (NASDAQ:SEPN) Shares Up 8.5%Should You Buy? - MarketBeat
Septerna plunges as safety concerns force an end to early-stage trial - MSN
How hedge fund analytics apply to Septerna Inc. stockJuly 2025 Review & Accurate Intraday Trade Tips - newser.com
Real time breakdown of Septerna Inc. stock performanceJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Is Septerna Inc. stock entering bullish territory2025 Winners & Losers & Long-Term Growth Plans - newser.com
Septerna, Inc. (NASDAQ:SEPN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
We're Not Worried About Septerna's (NASDAQ:SEPN) Cash Burn - Sahm
Are Options Traders Betting on a Big Move in Septerna Stock? - Yahoo Finance
Can Septerna Inc. stock hit analyst price targetsJuly 2025 Highlights & Entry Point Confirmation Signals - newser.com
Using RSI to spot recovery in Septerna Inc.Quarterly Risk Review & Long-Term Capital Growth Strategies - newser.com
Septerna Up 12%, Insider Buyers Are Up 219% - Yahoo Finance
Septerna appoints Keith Gottesdiener to board of directors By Investing.com - Investing.com Nigeria
Septerna Begins Phase 1 Trial for SEP-631 - MSN
Septerna, Inc. Expands Board with New R&D Chair - TipRanks
Septerna appoints Keith Gottesdiener to board of directors - Investing.com India
Former Prime Medicine CEO and 20+ Drug Approval Leader Keith Gottesdiener Joins Septerna's Board - Stock Titan
What analysts say about Septerna Inc stockContrarian Investment Ideas & Low Risk Investment Growth - Early Times
Septerna (NASDAQ:SEPN) Stock Price Up 9.2%Should You Buy? - MarketBeat
Technical signs of recovery in Septerna Inc.Trade Volume Summary & High Accuracy Trade Signal Alerts - newser.com
Septerna Inc. stock daily chart insightsExit Point & AI Enhanced Trading Alerts - newser.com
Septerna Inc Azioni (SEPN) Dati Finanziari
Non sono disponibili dati finanziari per Septerna Inc (SEPN). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Septerna Inc Azioni (SEPN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Finer Jeffrey | CEO and President |
Apr 02 '25 |
Option Exercise |
2.76 |
50,000 |
138,000 |
821,907 |
| Finer Jeffrey | CEO and President |
Apr 03 '25 |
Option Exercise |
2.76 |
5,000 |
13,800 |
826,907 |
| Ezekowitz Alan | Director |
Mar 07 '25 |
Buy |
6.93 |
13,319 |
92,270 |
117,420 |
| Ezekowitz Alan | Director |
Mar 06 '25 |
Buy |
6.00 |
41,355 |
248,130 |
104,101 |
| Ezekowitz Alan | Director |
Mar 05 '25 |
Buy |
5.82 |
37,835 |
220,260 |
62,746 |
| Ezekowitz Alan | Director |
Mar 04 '25 |
Buy |
6.35 |
7,491 |
47,544 |
24,911 |
| Finer Jeffrey | CEO and President |
Feb 25 '25 |
Buy |
5.68 |
10,000 |
56,765 |
764,907 |
| Finer Jeffrey | CEO and President |
Feb 26 '25 |
Buy |
5.70 |
4,000 |
22,796 |
768,907 |
| Finer Jeffrey | CEO and President |
Feb 27 '25 |
Buy |
5.80 |
3,000 |
17,400 |
771,907 |
| Labrucherie Gil M | Chief Financial Officer |
Feb 25 '25 |
Buy |
5.59 |
6,282 |
35,116 |
36,282 |
0.11%
2.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):